Understand the source comparison
AHK-Cu Alternatives 2026: Peptide Comparison
GHK-Cu Copper chelation → TGF-β activation → collagen synthesis Topical (liposomal), subcutaneous 1.2 hours (unmodified) Dermal, vascular endothelium Closest structural analog to AHK-Cu with superior copper-binding affinity (log K 16.44); requires penetration
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GHK-Cu
- Copper chelation → TGF-β activation → collagen synthesis
- Topical (liposomal), subcutaneous
- 1.2 hours (unmodified)
- Dermal, vascular endothelium
- Closest structural analog to AHK-Cu with superior copper-binding affinity (log K 16.44); requires penetration enhancement for topical efficacy
- Thymalin
- Thymic epithelial modulation → cytokine upregulation → immune-mediated repair
- Subcutaneous, intramuscular
- 4–6 hours
- Systemic (immune tissue, secondary wound sites)
- Divergent mechanism but overlapping regenerative outcomes; systemic effect benefits multi-tissue repair but lacks localized control
- Dihexa
- HGF mimicry → c-Met receptor activation → neuroplasticity signaling
- Oral, intranasal
- 2–3 hours
- Neural tissue (crosses BBB)
- Pathway-targeted for cognitive/neural applications; structurally unrelated to AHK-Cu but functionally equivalent in neuroplasticity contexts
- KPV
- NF-κB inhibition → anti-inflammatory cytokine suppression
- Oral, subcutaneous, topical
- 30–45 minutes
- GI mucosa, inflamed tissue
- Operates through inflammation control rather than direct synthesis stimulation; ideal for repair-inhibited environments
- Cartalax
- DNA binding → endothelial gene expression modulation
- Subcutaneous
- 3–5 hours
- Vascular endothelium
- Bioregulatory mechanism increases angiogenesis without direct ECM interaction; complements rather than replaces copper peptides